• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: INSULET CORPORATION OMNIPOD DASH INSULIN MANAGEMENT SYSTEM; PUMP, INFUSION, INSULIN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

INSULET CORPORATION OMNIPOD DASH INSULIN MANAGEMENT SYSTEM; PUMP, INFUSION, INSULIN Back to Search Results
Model Number 18320
Device Problem Insufficient Information (3190)
Patient Problems Dehydration (1807); Diarrhea (1811); Hyperglycemia (1905); Pain (1994); Vomiting (2144); Anxiety (2328)
Event Date 03/09/2023
Event Type  Injury  
Event Description
It was reported that the patient had been hospitalized with hyperglycemia.The patient's blood glucose levels reached 300 mg/dl while wearing the pod longer than 48 hours.Symptoms reported include shock, dehydration, a magnesium deficiency, a panic attack, vomiting and diarrhea.The patient was treated with fluids via iv, zofran, and benadryl due to the patient being allergic to zofran.The patient also got over the counter magnesium and pepcid.It was also stated that there was pain at the insertion site.The patient was released the following day.The pod was worn when seeking medical attention.
 
Manufacturer Narrative
According to the complainant the device will not be returned for investigation.We are unable to determine if any product condition could have contributed to the reported hospitalization and hyperglycemia.Lot release records were reviewed and the product lot met all acceptance criteria.Specifically, a pod is paired to a pdm and put through simulated use testing including communicating with the pdm, deployment, delivering fluid, occlusion detection, and freedom from hazard alarms.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OMNIPOD DASH INSULIN MANAGEMENT SYSTEM
Type of Device
PUMP, INFUSION, INSULIN
Manufacturer (Section D)
INSULET CORPORATION
100 nagog park
acton MA 01720
Manufacturer (Section G)
INSULET CORPORATION
100 nagog park
acton MA 01720
Manufacturer Contact
michael spears
100 nagog park
acton, MA 01720
9786007000
MDR Report Key16668535
MDR Text Key312589160
Report Number3004464228-2023-08763
Device Sequence Number1
Product Code LZG
UDI-Device Identifier20385082000020
UDI-Public(01)20385082000020(11)211206(17)230606(10)PD1K12062111
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K211575
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Other
Type of Report Initial
Report Date 03/30/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/03/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date06/06/2023
Device Model Number18320
Device Catalogue NumberBLE-I1-529
Device Lot NumberPD1K12062111
Was Device Available for Evaluation? No
Date Manufacturer Received03/30/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/06/2021
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age30 YR
Patient SexMale
-
-